Publications by authors named "F H Preston"

Article Synopsis
  • A tactical carcass optimisation tool (TCOT) was created with Australian lamb supply chains to help processors allocate lamb carcasses to cutting plans, maximizing daily profitability while overcoming challenges like carcass variability and product orders.
  • This model predicts product weights based on carcass characteristics, such as weight and fatness percentage, using advanced measurement techniques like dual-energy X-ray absorptiometry (DXA).
  • The TCOT showed potential in case studies, highlighting its ability to optimize cutting plans and improve profitability by at least 1% for processors in the domestic lamb market compared to current methods.
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the link between SGLT2 inhibitors and GLP-1 receptor agonists in relation to gout occurrence among type 2 diabetes patients using real-world data.
  • A cohort study was conducted, where patients on metformin or insulin with either SGLT2i or GLP-1Ra were matched based on characteristics and assessed over five years for gout incidence.
  • Results indicated that SGLT2i use significantly reduced gout incidence compared to control groups, whereas GLP-1Ra showed no significant difference, suggesting that SGLT2i might be a better option for preventing gout in these patients.
View Article and Find Full Text PDF

Purpose: To determine the degree of static eyelid asymmetry required to be perceptible and whether this is affected by image inversion.

Methods: Images of 3 volunteers were digitally manipulated to have eyelid asymmetry of 0.5 mm, 1 mm, or 1.

View Article and Find Full Text PDF

Introduction: A safety data sheet (SDS) is an established hazard communication tool for chemicals, for which no comparable document exists in the biotherapeutics industry. As the cell and gene therapy (CGT) field expands, industry leaders have identified a growing need to address this gap in communication of the unique occupational health and safety risks posed by CGT materials and products.

Methods: Following the sections of a traditional chemical SDS, information was modified by industry subject matter experts, relevant to CGT biological materials.

View Article and Find Full Text PDF

Introduction: This article provides a strategy by which a manufacturing process with a Biosafety Level 2 (BL2) designation can be downgraded to Biosafety Level 1 (BL1). The principles of the downgrading process are based on the robust contamination controls in clinical and commercial manufacturing, which typically are not part of Research and Development processes. These strict requirements along with the application of current Good Manufacturing Practice (cGMP) principles provide a framework by which processes can be suitably managed and controlled to mitigate biohazard risk, specifically for cell lines that may be contaminated with human pathogenic viral agents.

View Article and Find Full Text PDF